Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Sex differences in the involvement of spinal brain-derived neurotrophic factor (BDNF) in chronic pain
EF 2013-14
Résumé
Neuropathic pain is a chronic condition characterized by mild to severe pain and resulting in significant human suffering and economic burden (Woolf & Salter, 2000). The mechanisms underlying neuropathic pain in the spinal cord have been extensively investigated in the past decade. The current model of neuropathic pain consists of activation of microglia (immune-cell subtype) resulting in a signal (p38 MAP kinase) which causes the release of a molecule called brain-derived neurotrophic factor (BDNF) (Tsuda et al., 2003; Coull et al. 2005; Trang et al., 2009). BDNF increases the activity of pain relevant cells in the spinal cord by decreasing the amount of potassium chloride cotransporter (KCC2) (Coull et al., 2003; Coull et al., 2005). However, the animal research that has been conducted to determine these mechanisms has included only male subjects and may not be relevant to a female population (Mogil & Chanda, 2005). This is serious issue when attempting to apply animal research findings to humans given that the majority of individuals with chronic pain are female (Berkley, 1997). Recent research has indicated that neuropathic pain in female mice does not involve microglia (unpublished data). Instead, neuropathic pain in females appears to use another immune cell called T-cells. However, female mice can use the male system if they are lacking T-cells. My project aims to develop a better understanding of the mechanisms underlying neuropathic pain in females. My hypothesis is that the mechanisms underlying neuropathic pain in females works in a similar manner to the male system except that BDNF is released from T-cells instead of microglia. First, the role of BDNF in females will be determined by applying BDNF to the spinal cord and blocking BDNF after a surgery inducing neuropathic pain. Second, the role of BDNF from T-cells will be determined through breeding of mice who do not have BDNF released from T-cells. Third, the role of KCC2 will be determined in females through testing the effects of drugs that increase and decrease the amount of KCC2. Finally, the role of p38 map kinase will be determined by inhibiting the kinase with a drug in mice with neuropathic pain. My project has the potential to have a significant impact on the field of pain research. Previous attempts at developing treatments for neuropathic pain have been largely unsuccessful. Development of treatments that are actually based on female relevant mechanisms may improve this issue. Eventually, I anticipate that the inclusion of female subjects will become a requirement in pain research and will lead to gender-specific, effective treatments for pain.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
311918
Name
Mapplebeck Josiane C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Sex differences in the involvement of spinal brain-derived neurotrophic factor (BDNF) in chronic pain
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bdnf; Chronic Pain; Kcc2; Microglia; Neuropathic Pain; P38 Map Kinase; Sex Differences; Sni; T-Cells; Trkb
Abstract
Neuropathic pain is a chronic condition characterized by mild to severe pain and resulting in significant human suffering and economic burden (Woolf & Salter, 2000). The mechanisms underlying neuropathic pain in the spinal cord have been extensively investigated in the past decade. The current model of neuropathic pain consists of activation of microglia (immune-cell subtype) resulting in a signal (p38 MAP kinase) which causes the release of a molecule called brain-derived neurotrophic factor (BDNF) (Tsuda et al., 2003; Coull et al. 2005; Trang et al., 2009). BDNF increases the activity of pain relevant cells in the spinal cord by decreasing the amount of potassium chloride cotransporter (KCC2) (Coull et al., 2003; Coull et al., 2005). However, the animal research that has been conducted to determine these mechanisms has included only male subjects and may not be relevant to a female population (Mogil & Chanda, 2005). This is serious issue when attempting to apply animal research findings to humans given that the majority of individuals with chronic pain are female (Berkley, 1997). Recent research has indicated that neuropathic pain in female mice does not involve microglia (unpublished data). Instead, neuropathic pain in females appears to use another immune cell called T-cells. However, female mice can use the male system if they are lacking T-cells. My project aims to develop a better understanding of the mechanisms underlying neuropathic pain in females. My hypothesis is that the mechanisms underlying neuropathic pain in females works in a similar manner to the male system except that BDNF is released from T-cells instead of microglia. First, the role of BDNF in females will be determined by applying BDNF to the spinal cord and blocking BDNF after a surgery inducing neuropathic pain. Second, the role of BDNF from T-cells will be determined through breeding of mice who do not have BDNF released from T-cells. Third, the role of KCC2 will be determined in females through testing the effects of drugs that increase and decrease the amount of KCC2. Finally, the role of p38 map kinase will be determined by inhibiting the kinase with a drug in mice with neuropathic pain. My project has the potential to have a significant impact on the field of pain research. Previous attempts at developing treatments for neuropathic pain have been largely unsuccessful. Development of treatments that are actually based on female relevant mechanisms may improve this issue. Eventually, I anticipate that the inclusion of female subjects will become a requirement in pain research and will lead to gender-specific, effective treatments for pain.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mapplebeck, Josiane C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~